These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 7255768)

  • 41. Further evidence for a dissociation of peripheral and central effects of vasopressin.
    Gaffori O; de Wied D
    Psychoneuroendocrinology; 1985; 10(4):439-44. PubMed ID: 4089084
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inhibition of vasopressin-stimulated flank marking behavior by V1-receptor antagonists.
    Ferris CF; Singer EA; Meenan DM; Albers HE
    Eur J Pharmacol; 1988 Sep; 154(2):153-9. PubMed ID: 2976377
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Behavioral effects of intraventricularly administered vasopressin and vasopressin fragments.
    de Wied D
    Life Sci; 1976 Sep; 19(5):685-90. PubMed ID: 957900
    [No Abstract]   [Full Text] [Related]  

  • 44. Cardiovascular responses to intrathecal administration of arginine vasopressin in rats.
    Riphagen CL; Pittman QJ
    Regul Pept; 1985 Apr; 10(4):293-8. PubMed ID: 3839086
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Facilitation of passive avoidance response by newly synthesized cationized arginine vasopressin fragment 4-9 in rats.
    Tanabe S; Shishido Y; Furushiro M; Kado K; Hashimoto S; Yokokura T; Ohsawa T
    Pharmacol Biochem Behav; 1997; 57(1-2):251-6. PubMed ID: 9164579
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Neonatal vasopressin antagonist treatment facilitates adult copulatory behavior in female rats and increases hypothalamic vasopressin content.
    Meyerson BJ; Höglund U; Johansson C; Blomqvist A; Ericson H
    Brain Res; 1988 Nov; 473(2):344-51. PubMed ID: 3233496
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Differential effects of centrally injected AVP on heart rate, core temperature, and behavior in rats.
    Diamant M; De Wied D
    Am J Physiol; 1993 Jan; 264(1 Pt 2):R51-61. PubMed ID: 8430886
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Structure activity relationship studies with C-terminal fragments of vasopressin and oxytocin on avoidance behaviors of rats.
    de Wied D; Gaffori O; Burbach JP; Kovács GL; van Ree JM
    J Pharmacol Exp Ther; 1987 Apr; 241(1):268-74. PubMed ID: 3572787
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evidence against role of antidiuretic hormone in support of blood pressure during dehydration.
    Fejes-Tóth G; Náray-Fejes-Tóth A; Ratge D
    Am J Physiol; 1985 Jul; 249(1 Pt 2):H42-8. PubMed ID: 2990241
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Differential effects of dPTyr(Me)AVP, a vasopressin antagonist, upon foot shock analgesia.
    Kordower JH; Bodnar RJ
    Int J Neurosci; 1985 Dec; 28(3-4):269-78. PubMed ID: 3005187
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Aversive effects of subcutaneously injected vasopressin in the rat: independence of the ascending dorsal noradrenergic bundle.
    Tam FW; Chen C; Alpert JE; Iversen SD
    Brain Res; 1985 Jun; 337(1):133-7. PubMed ID: 3924347
    [TBL] [Abstract][Full Text] [Related]  

  • 52. No. 302, a newly synthesized [pGlu4,Cyt6]AVP(4-9) analogue, prevents the disruption of avoidance behavior.
    Hirate K; Hirano M; Nakajima Y; Hiyama A; Maeda O; Asakura W
    Behav Brain Res; 1997 Feb; 83(1-2):205-8. PubMed ID: 9062685
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Can vasopressin alone act as an unconditioned stimulus to produce passive avoidance behaviour in rats in a typical memory experiment?
    Ebenezer IS
    Neuropharmacology; 1988 Sep; 27(9):903-7. PubMed ID: 3185866
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Central and systemic effects of a vasopressin V1 antagonist on MAP recovery after haemorrhage in rats.
    Johnson JV; Bennett GW; Hatton R
    J Cardiovasc Pharmacol; 1988 Oct; 12(4):405-12. PubMed ID: 2465440
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Arginine vasopressin increases renal sodium excretion in the anesthetized rat through V1 receptors.
    Musabayane CT; Forsling ML; Balment RJ
    Ren Fail; 1997 Jan; 19(1):23-32. PubMed ID: 9044449
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Intracerebroventricular application of a vasopressin antagonist peptide prevents the behavioral actions of vasopressin.
    Ettenberg A
    Behav Brain Res; 1984 Dec; 14(3):201-11. PubMed ID: 6549259
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Identification and characterization of arginine vasopressin receptors in the rat testis.
    Meidan R; Hsueh AJ
    Endocrinology; 1985 Jan; 116(1):416-23. PubMed ID: 2981073
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Septal vasopressin modulates motility and passive avoidance in pinealectomized rats.
    Appenrodt E; Schwarzberg H
    Physiol Behav; 1999 Jul; 66(5):757-61. PubMed ID: 10405103
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Role of nitric oxide in systemic vasopressin-induced hypothermia.
    Steiner AA; Carnio EC; Antunes-Rodrigues J; Branco LG
    Am J Physiol; 1998 Oct; 275(4):R937-41. PubMed ID: 9756520
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cysteinyl methyl ester of AVP(4-8), a potent agonist on the maintenance of passive avoidance in rats.
    Lin C; Liu RY; Du YC
    Peptides; 1990; 11(4):633-9. PubMed ID: 2235674
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.